Introduction: Calpain small subunit 1 (Capns1) has shown its correlation with the metastasis and invasion of hepatocellular carcinoma and intrahepatic cholangiocarcinoma. However, the expression and function of Capns1 in human renal cell carcinoma (RCC) have not been clarified. This study aimed to examine the expression of Capns1 in RCC tissues and cell lines and to assess its role performed in RCC. Methods: Capns1 expression was evaluated in 75 pairs of RCC and matched adjacent non-tumor tissues by immunohistochemistry. The prognostic value of Capns1 in RCC was assessed by Kaplan-Meier and Cox regression analyses. The action of Capns1 in the proliferation, adhesion, migration, and invasion of RCC cells and the effects on matrix metalloproteinase (MMP) 2 and 9 expression were evaluated after Capns1 silence. Results: Capns1 expression was significantly higher in RCC tissues compared with the adjacent non-tumor tissues. Multivariate analysis showed that Capns1 overexpression was an independent poor prognostic marker in RCC. The silencing of Capns1 prohibited cell adhesion and impaired the migration and invasion ability of 786-O cells in vitro. Furthermore, Capns1 silence reduced MMP2 and MMP9 expression. Conclusion: Capns1 overexpression predicts poor prognosis and correlates with tumor progression in RCC. Capns1 expression might serve a prognostic marker and therapeutic target for RCC.

1.
Owens
B
.
Kidney cancer
.
Nature
.
2016
;
537
(
7620
):
S97
. .
2.
Siegel
RL
,
Miller
KD
,
Jemal
A
.
Cancer statistics, 2016
.
CA Cancer J Clin
.
2019
;
66
(
1
):
7
30
. .
3.
Matsuura
K
,
Nakada
C
,
Mashio
M
,
Narimatsu
T
,
Yoshimoto
T
,
Tanigawa
M
, et al.
Downregulation of SAV1 plays a role in pathogenesis of high-grade clear cell renal cell carcinoma
.
BMC cancer
.
2011
;
11
(
1
):
523
. .
4.
Yaycioglu
O
,
Eskicorapci
S
,
Karabulut
E
,
Soyupak
B
,
Gogus
C
,
Divrik
T
, et al.
A preoperative prognostic model predicting recurrence-free survival for patients with kidney cancer
.
Jpn J Clin Oncol
.
2013
;
43
(
1
):
63
8
. .
5.
Li
M
,
Bu
R
.
Biological support to obesity paradox in renal cell carcinoma: a review
.
Urol Int
.
2020
:
104
(
11–12
):
837
48
.
6.
Goll
DE
,
Thompson
VF
,
Li
H
,
Wei
W
,
Cong
J
.
The calpain system
.
Physiol Rev
.
2003
;
83
(
3
):
731
801
. .
7.
Saez
ME
,
Ramirez-Lorca
R
,
Moron
FJ
,
Ruiz
A
.
The therapeutic potential of the calpain family: new aspects
.
Drug Discov Today
.
2006
;
11
(
19–20
):
917
23
. .
8.
Huttenlocher
A
,
Palecek
SP
,
Lu
Q
,
Zhang
W
,
Mellgren
RL
,
Lauffenburger
DA
, et al.
Regulation of cell migration by the calcium-dependent protease calpain
.
J Biol Chem
.
1997
;
272
(
52
):
32719
22
. .
9.
Dourdin
N
,
Bhatt
AK
,
Dutt
P
,
Greer
PA
,
Arthur
JS
,
Elce
JS
, et al.
Reduced cell migration and disruption of the actin cytoskeleton in calpain-deficient embryonic fibroblasts
.
J Biol Chem
.
2001
;
276
(
51
):
48382
8
. .
10.
De Robertis
R
,
Cingarlini
S
,
Tinazzi Martini
P
,
Ortolani
S
,
Butturini
G
,
Landoni
L
, et al.
Pancreatic neuroendocrine neoplasms: magnetic resonance imaging features according to grade and stage
.
World J Gastroenterol
.
2017
;
23
(
2
):
275
85
. .
11.
Zhu
G
,
Briz
V
,
Seinfeld
J
,
Liu
Y
,
Bi
X
,
Baudry
M
.
Calpain-1 deletion impairs mGluR-dependent LTD and fear memory extinction
.
Sci Rep
.
2017
;
7
:
42788
. .
12.
Zhu
G
,
Liu
Y
,
Wang
Y
,
Bi
X
,
Baudry
M
.
Different patterns of electrical activity lead to long-term potentiation by activating different intracellular pathways
.
J Neurosci
.
2015
;
35
(
2
):
621
33
. .
13.
Carragher
NO
,
Fonseca
BD
,
Frame
MC
.
Calpain activity is generally elevated during transformation but has oncogene-specific biological functions
.
Neoplasia
.
2004
;
6
(
1
):
53
. .
14.
Arthur
JS
,
Greer
PA
,
Elce
JS
.
Structure of the mouse calpain small subunit gene
.
Biochim Biophys Acta
.
1998
;
1388
(
1
):
247
52
. .
15.
Tan
Y
,
Dourdin
N
,
Wu
C
,
De Veyra
T
,
Elce
JS
,
Greer
PA
.
Conditional disruption of ubiquitous calpains in the mouse
.
Genesis
.
2006
;
44
(
6
):
297
303
. .
16.
Amini
M
,
Ma
CL
,
Farazifard
R
,
Zhu
G
,
Zhang
Y
,
Vanderluit
J
, et al.
Conditional disruption of calpain in the CNS alters dendrite morphology, impairs LTP, and promotes neuronal survival following injury
.
J Neurosci
.
2013
;
33
(
13
):
5773
84
. .
17.
Arthur
JS
,
Elce
JS
,
Hegadorn
C
,
Williams
K
,
Greer
PA
.
Disruption of the murine calpain small subunit gene, Capn4: calpain is essential for embryonic development but not for cell growth and division
.
Mol Cell Biol
.
2000
;
20
(
12
):
4474
81
. .
18.
Bai
DS
,
Dai
Z
,
Zhou
J
,
Liu
YK
,
Qiu
SJ
,
Tan
CJ
, et al.
Capn4 overexpression underlies tumor invasion and metastasis after liver transplantation for hepatocellular carcinoma
.
Hepatology
.
2009
;
49
(
2
):
460
70
. .
19.
Zhang
C
,
Bai
DS
,
Huang
XY
,
Shi
GM
,
Ke
AW
,
Yang
LX
, et al.
Prognostic significance of Capn4 overexpression in intrahepatic cholangiocarcinoma
.
PLoS One
.
2013
;
8
(
1
):
e54619
. .
20.
Livak
KJ
,
Schmittgen
TD
.
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method
.
Methods
.
2001
;
25
(
4
):
402
8
. .
21.
Zhuang
Q
,
Qian
X
,
Cao
Y
,
Fan
M
,
Xu
X
,
He
X
.
Capn4 mRNA level is correlated with tumour progression and clinical outcome in clear cell renal cell carcinoma
.
J Int Med Res
.
2014
;
42
(
2
):
282
91
. .
22.
Dourdin
N
,
Bhatt
AK
,
Dutt
P
,
Greer
PA
,
Arthur
JS
,
Elce
JS
, et al.
Reduced cell migration and disruption of the actin cytoskeleton in calpain-deficient embryonic fibroblasts
.
J Biol Chem
.
2001
;
276
(
51
):
48382
8
. .
23.
Mellgren
RL
,
Zhang
W
,
Miyake
K
,
McNeil
PL
.
Calpain is required for the rapid, calcium-dependent repair of wounded plasma membrane
.
J Biol Chem
.
2007
;
282
(
4
):
2567
75
. .
24.
Zhu
G
,
Li
J
,
He
L
,
Wang
X
,
Hong
X
.
MPTP-induced changes in hippocampal synaptic plasticity and memory are prevented by memantine through the BDNF-TrkB pathway
.
Br J Pharmacol
.
2015
;
172
(
9
):
2354
68
. .
25.
Kwak
HI
,
Kang
H
,
Dave
JM
,
Mendoza
EA
,
Su
SC
,
Maxwell
SA
, et al.
Calpain-mediated vimentin cleavage occurs upstream of MT1-MMP membrane translocation to facilitate endothelial sprout initiation
.
Angiogenesis
.
2012
;
15
(
2
):
287
303
. .
26.
Jiang
L
,
Zhang
J
,
Monticone
RE
,
Telljohann
R
,
Wu
J
,
Wang
M
, et al.
Calpain-1 regulation of matrix metalloproteinase 2 activity in vascular smooth muscle cells facilitates age-associated aortic wall calcification and fibrosis
.
Hypertension
.
2012
;
60
(
5
):
1192
9
. .
27.
Moser
B
,
Loetscher
P
.
Lymphocyte traffic control by chemokines
.
Nat Immunol
.
2001
;
2
(
2
):
123
8
. .
28.
Kryczek
I
,
Bruce
AT
,
Gudjonsson
JE
,
Johnston
A
,
Aphale
A
,
Vatan
L
, et al.
Induction of IL-17+ T cell trafficking and development by IFN-gamma: mechanism and pathological relevance in psoriasis
.
J Immunol
.
2008
;
181
(
7
):
4733
41
. .
29.
Kuang
DM
,
Peng
C
,
Zhao
Q
,
Wu
Y
,
Chen
MS
,
Zheng
L
.
Activated monocytes in peritumoral stroma of hepatocellular carcinoma promote expansion of memory T helper 17 cells
.
Hepatology
.
2010
;
51
(
1
):
154
64
. .
30.
Shibata
T
,
Tahara
T
,
Hirata
I
,
Arisawa
T
.
Genetic polymorphism of interleukin-17A and -17F genes in gastric carcinogenesis
.
Hum Immunol
.
2009
;
70
(
7
):
547
51
. .
31.
Maruyama
T
,
Kono
K
,
Mizukami
Y
,
Kawaguchi
Y
,
Mimura
K
,
Watanabe
M
, et al.
Distribution of Th17 cells and FoxP3(+) regulatory T cells in tumor-infiltrating lymphocytes, tumor-draining lymph nodes and peripheral blood lymphocytes in patients with gastric cancer
.
Cancer Sci
.
2010
;
101
(
9
):
1947
54
. .
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.